Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ZURICH, April 25, 2013 /PRNewswire/ --

- Phase 2b clinical trial of CYT003 in allergic asthma on-going as planned

- Cytos' VLP platform is basis for a phase 1 clinical trial with an Anti-lgE Vaccine partnered with and conducted by Pfizer

Help employers find you! Check out all the jobs and post your resume.

Back to news